These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

719 related items for PubMed ID: 19576267

  • 1. Rapid antidepressant effects of sleep deprivation therapy correlates with serum BDNF changes in major depression.
    Gorgulu Y, Caliyurt O.
    Brain Res Bull; 2009 Sep 28; 80(3):158-62. PubMed ID: 19576267
    [Abstract] [Full Text] [Related]

  • 2. Partial sleep deprivation therapy combined with sertraline induces more rapid improvements in quality of life items in major depressive disorder.
    Caliyurt O, Guducu F.
    J Affect Disord; 2005 Sep 28; 88(1):75-8. PubMed ID: 15967511
    [Abstract] [Full Text] [Related]

  • 3. [Combination therapy using sertraline with sleep deprivation and light therapy compared to sertraline monotherapy for major depressive disorder].
    Güdücü F, Caliyurt O, Vardar E, Tuğlu C, Abay E.
    Turk Psikiyatri Derg; 2005 Sep 28; 16(4):245-51. PubMed ID: 16362843
    [Abstract] [Full Text] [Related]

  • 4. Serum brain-derived neurotrophic factor levels in patients with major depression: effects of antidepressants.
    Huang TL, Lee CT, Liu YL.
    J Psychiatr Res; 2008 Jun 28; 42(7):521-5. PubMed ID: 17585940
    [Abstract] [Full Text] [Related]

  • 5. Partial sleep deprivation therapy combined with sertraline affects subjective sleep quality in major depressive disorder.
    Caliyurt O, Guducu F.
    Sleep Med; 2005 Nov 28; 6(6):555-9. PubMed ID: 15994121
    [Abstract] [Full Text] [Related]

  • 6. High-frequency repetitive transcranial magnetic stimulation improves refractory depression by influencing catecholamine and brain-derived neurotrophic factors.
    Yukimasa T, Yoshimura R, Tamagawa A, Uozumi T, Shinkai K, Ueda N, Tsuji S, Nakamura J.
    Pharmacopsychiatry; 2006 Mar 28; 39(2):52-9. PubMed ID: 16555165
    [Abstract] [Full Text] [Related]

  • 7. Plasma Brain-Derived Neurotrophic Factor in treatment-resistant depressed patients receiving electroconvulsive therapy.
    Piccinni A, Del Debbio A, Medda P, Bianchi C, Roncaglia I, Veltri A, Zanello S, Massimetti E, Origlia N, Domenici L, Marazziti D, Dell'Osso L.
    Eur Neuropsychopharmacol; 2009 May 28; 19(5):349-55. PubMed ID: 19223156
    [Abstract] [Full Text] [Related]

  • 8. Plasma and serum brain-derived neurotrophic factor (BDNF) in depressed patients during 1 year of antidepressant treatments.
    Piccinni A, Marazziti D, Catena M, Domenici L, Del Debbio A, Bianchi C, Mannari C, Martini C, Da Pozzo E, Schiavi E, Mariotti A, Roncaglia I, Palla A, Consoli G, Giovannini L, Massimetti G, Dell'Osso L.
    J Affect Disord; 2008 Jan 28; 105(1-3):279-83. PubMed ID: 17553570
    [Abstract] [Full Text] [Related]

  • 9. Effect of repetitive transcranial magnetic stimulation on serum brain derived neurotrophic factor in drug resistant depressed patients.
    Zanardini R, Gazzoli A, Ventriglia M, Perez J, Bignotti S, Rossini PM, Gennarelli M, Bocchio-Chiavetto L.
    J Affect Disord; 2006 Mar 28; 91(1):83-6. PubMed ID: 16448701
    [Abstract] [Full Text] [Related]

  • 10. Serum levels of brain-derived neurotrophic factor in comorbidity of depression and alcohol dependence.
    Umene-Nakano W, Yoshimura R, Ikenouchi-Sugita A, Hori H, Hayashi K, Ueda N, Nakamura J.
    Hum Psychopharmacol; 2009 Jul 28; 24(5):409-13. PubMed ID: 19548207
    [Abstract] [Full Text] [Related]

  • 11. Fast BDNF serum level increase and diurnal BDNF oscillations are associated with therapeutic response after partial sleep deprivation.
    Giese M, Beck J, Brand S, Muheim F, Hemmeter U, Hatzinger M, Holsboer-Trachsler E, Eckert A.
    J Psychiatr Res; 2014 Dec 28; 59():1-7. PubMed ID: 25258340
    [Abstract] [Full Text] [Related]

  • 12. Changes in CREB phosphorylation and BDNF plasma levels during psychotherapy of depression.
    Koch JM, Hinze-Selch D, Stingele K, Huchzermeier C, Goder R, Seeck-Hirschner M, Aldenhoff JB.
    Psychother Psychosom; 2009 Dec 28; 78(3):187-92. PubMed ID: 19321972
    [Abstract] [Full Text] [Related]

  • 13. Serum brain-derived neurotrophic factor level in dysthymia: a comparative study with major depressive disorder.
    Aydemir O, Deveci A, Taskin OE, Taneli F, Esen-Danaci A.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun 30; 31(5):1023-6. PubMed ID: 17433517
    [Abstract] [Full Text] [Related]

  • 14. Low plasma brain-derived neurotrophic factor and childhood physical neglect are associated with verbal memory impairment in major depression--a preliminary report.
    Grassi-Oliveira R, Stein LM, Lopes RP, Teixeira AL, Bauer ME.
    Biol Psychiatry; 2008 Aug 15; 64(4):281-5. PubMed ID: 18406398
    [Abstract] [Full Text] [Related]

  • 15. Electroconvulsive Therapy (ECT) increases serum Brain Derived Neurotrophic Factor (BDNF) in drug resistant depressed patients.
    Bocchio-Chiavetto L, Zanardini R, Bortolomasi M, Abate M, Segala M, Giacopuzzi M, Riva MA, Marchina E, Pasqualetti P, Perez J, Gennarelli M.
    Eur Neuropsychopharmacol; 2006 Dec 15; 16(8):620-4. PubMed ID: 16757154
    [Abstract] [Full Text] [Related]

  • 16. Addition of risperidone to sertraline improves sertraline-resistant refractory depression without influencing plasma concentrations of sertraline and desmethylsertraline.
    Yoshimura R, Umene-Nakano W, Ueda N, Ikenouchi-Sugita A, Hori H, Nakamura J.
    Hum Psychopharmacol; 2008 Dec 15; 23(8):707-13. PubMed ID: 18803170
    [Abstract] [Full Text] [Related]

  • 17. Serum brain-derived neurotrophic factor (BDNF) levels in patients with panic disorder: as a biological predictor of response to group cognitive behavioral therapy.
    Kobayashi K, Shimizu E, Hashimoto K, Mitsumori M, Koike K, Okamura N, Koizumi H, Ohgake S, Matsuzawa D, Zhang L, Nakazato M, Iyo M.
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jun 15; 29(5):658-63. PubMed ID: 15905010
    [Abstract] [Full Text] [Related]

  • 18. [Blood levels of brain-derived neurotrophic factor (BDNF) in major depressive disorder].
    Yoshimura R, Ikenouchi-Sugita A, Hori H, Umene-Nakano W, Hayashi K, Katsuki A, Ueda N, Nakamura J.
    Seishin Shinkeigaku Zasshi; 2010 Jun 15; 112(10):982-5. PubMed ID: 21179660
    [Abstract] [Full Text] [Related]

  • 19. The acute response of plasma brain-derived neurotrophic factor as a result of exercise in major depressive disorder.
    Gustafsson G, Lira CM, Johansson J, Wisén A, Wohlfart B, Ekman R, Westrin A.
    Psychiatry Res; 2009 Oct 30; 169(3):244-8. PubMed ID: 19729204
    [Abstract] [Full Text] [Related]

  • 20. BDNF, interleukin-6, and salivary cortisol levels in depressed patients treated with desvenlafaxine.
    Ninan PT, Shelton RC, Bao W, Guico-Pabia CJ.
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan 03; 48():86-91. PubMed ID: 24096053
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.